Docetaxel

    October 1995 in “ Journal of clinical oncology ”
    J E Cortes, Richard Pazdur
    Studysummary This review details the preclinical and early clinical activity and side effects of docetaxel, showing its significant effectiveness against various cancers with neutropenia as a major side effect.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ascopubs.org →
    Discuss this study in the Community →